Beenish S Manzoor
8PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 07, 2025
Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis.Gijs van de Wetering, Carolyn Owen, Versha Banerji
|Dec 20, 2024
Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia.Scott F Huntington, Joanna M Rhodes, Beenish S Manzoor
|Jul 25, 2024
Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia.Nilanjan Ghosh, Beenish S Manzoor, Bita Fakhri
|Jun 11, 2024
Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experiment.Arliene Ravelo, Kelley Myers, Robyn Brumble
|Apr 16, 2024
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting.Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor
|Aug 25, 2023
Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.Tara Cochrane, Alicia Enrico, David Gomez-Almaguer
Pageof 2
Frequent Collaborators
2 joint publications
Bita Fakhri
1 joint publications
Tara Cochrane
1 joint publications
Alicia Enrico
1 joint publications
David Gomez-Almaguer
1 joint publications
Evgueniy Hadjiev
1 joint publications
Tamas Masszi
1 joint publications
Eugene Nikitin
1 joint publications
Tadeusz Robak
1 joint publications
Robert Weinkove
1 joint publications
Mary Ann Anderson
